Trial Profile
Post-Marketing Surveillance of Acofide in Patients with Functional Dyspepsia
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2016
Price :
$35
*
At a glance
- Drugs Acotiamide (Primary)
- Indications Non-ulcer dyspepsia
- Focus Adverse reactions
- Sponsors Astellas Pharma; Zeria
- 06 Sep 2016 Status changed from recruiting to active, no longer recruiting.
- 08 Jun 2016 New trial record